Carlsmed

Carlsbad, CA All United States companies → — Founded 2018

Medical Device / Hardware Specialty-Focused AI

Neurosurgery Orthopedics Radiology

Radiology & Imaging AI Surgical AI

Public — $110M

Website Claim this company

Products

aprevo® Digital Segmentation

Carlsmed

Radiology & Imaging AI

AI-powered software for precise 3D segmentation of spinal DICOM images, enabling personalized surgical planning for spine fusion procedures.

Contact for pricing

See all 1 product →

About Carlsmed

Carlsmed is a commercial-stage medical technology company that pioneers AI-enabled personalized spine surgery solutions. Their core mission is to enhance patient outcomes and reduce healthcare costs associated with spine surgery by transforming the standard of care. The company’s proprietary aprevo® Technology Platform integrates advanced AI-driven software with 3D-printed, patient-specific interbody fusion devices.

This platform enables detailed 3D surgical planning, leveraging AI-enabled segmentation and prior outcomes data to develop personalized surgical plans and devices tailored to each patient’s unique anatomy and pathology. Initially focused on lumbar fusion procedures, Carlsmed has expanded its offerings to include cervical fusion surgeries, with recent launches and clinical evaluations of its aprevo® Cervical Interbody System and corra™ Cervical Plating System. The technology aims to provide precise alignment, optimized fit, and has demonstrated a significant reduction in revision rates compared to standard implants.

What Physicians Need to Know

AI-Powered Personalized Spine Surgery

Carlsmed specializes in AI-enabled personalized spine fusion solutions, utilizing its aprevou00ae platform for both cervical and lumbar procedures. This approach leverages artificial intelligence to tailor surgical plans to each patient's unique anatomy and pathology.

Digital Twin & 3D Printing Technology

The aprevou00ae platform employs proprietary digital twin technology to create a precise virtual replica of each patient's unique spinal anatomy and alignment. This digital model then informs the 3D printing of patient-specific implants, moving beyond conventional off-the-shelf solutions.

Predictive Surgical Planning & Outcome Optimization

Carlsmed offers predictive analytics by simulating thousands of surgical scenarios to determine optimal surgical plans and patient-specific implant designs. This aims to significantly improve clinical outcomes, reduce surgical complications, and lower revision rates, with reported data showing a 74% reduction in reoperations for lumbar procedures.

Patient-Specific Implants & Alignment

A key differentiator is the ability to design and provide implants precisely tailored to an individual's unique anatomy and pathology. These implants are engineered to achieve specific sagittal and coronal alignment goals, enhancing surgical precision.

End-to-End Digital Workflow

The aprevou00ae platform provides an integrated, end-to-end digital solution encompassing preoperative planning, 'just-in-time' delivery of sterile, customized implants, intra-operative support via the myaprevou00ae app for 3D visualizations, and post-operative data collection for continuous algorithm training and improvement.

Physician Tip

Carlsmed's aprevou00ae platform offers spine surgeons a transformative approach by integrating AI-driven personalized planning with patient-specific 3D-printed implants. This enables unparalleled precision in achieving optimal spinal alignment and significantly reduces the risk of complications and revision surgeries, as evidenced by clinical data. Physicians benefit from a comprehensive pre-operative understanding through digital twin technology, intuitive 3D visualizations via the myaprevou00ae app for intra-operative guidance, and the flexibility to adapt plans. The system supports data-driven decision-making, streamlines workflows, and is designed to complement existing surgical navigation and robotic systems, ultimately leading to more predictable and improved long-term patient outcomes. Furthermore, the CMS New Technology Add-On Payment (NTAP) for cervical fusion procedures can provide elevated reimbursement for hospitals, making this innovative technology more accessible.

While the provided sources highlight an end-to-end digital workflow and compatibility with current surgical navigation and spinal robot software, specific details regarding direct integrations with Electronic Medical Records (EMRs), Picture Archiving and Communication Systems (PACS), or other hospital IT infrastructure are not explicitly detailed. Further inquiry would be needed to understand their full integration capabilities.

At a glance

Founded 2018

HQ Carlsbad, CA · United States

Team size 133

CEO Mike Cordonnier

Funding Public — $110M

Products 1

Visit site

Products by Carlsmed

1 product in the directory

aprevo® Digital Segmentation

Carlsmed

Radiology & Imaging AI

AI-powered software for precise 3D segmentation of spinal DICOM images, enabling personalized surgical planning for spine fusion procedures.

Contact for pricing

What the Web Says

Carlsmed is a medical technology company specializing in personalized spine fusion devices, particularly aprevo. The company has received positive attention for its innovative, patient-specific approach to spinal surgery, aiming to improve outcomes and reduce complications. While product reviews highlight the potential benefits for patients and surgeons, employer reviews are less prevalent, but generally indicate a positive work environment.

Overall: Positive

Strengths

Personalized, patient-specific implants (aprevo) lead to better surgical outcomes.
Utilizes AI and predictive analytics for surgical planning.
Potential to reduce complications and reoperations.
Positive impact on patient recovery and quality of life.
Strong focus on innovation and technological advancement.
Collaborative and supportive work culture (based on limited employer reviews).

Limitations

Limited availability of comprehensive employer reviews on major platforms.
As a newer technology, long-term efficacy data is still accumulating.
Potential for higher costs associated with personalized implants compared to standard options.
Adoption rate may be slow due to the need for new surgical workflows.
Specific product reviews from platforms like G2 or Capterra are not readily available as it's a medical device.
No significant negative product or company reviews found across searched platforms.

Based on reviews from: GlobeNewswire, Healthcare IT News, Spine publications/journals (implied from product reviews), LinkedIn (for employer insights), Reddit (limited relevant discussions)

Last updated: 2026-07-20

Videos

News, demos, and interviews about Carlsmed.

Loading videos...

Videos load interactively. If none appear, search YouTube for Carlsmed →

View all on YouTube

Press & Coverage

GlobeNewswire

Carlsmed Announces U.S. Launch of its aprevou00ae Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting

Carlsmed announced the U.S. commercial launch of its aprevou00ae Technology Platform for cervical fusion surgeries, with early clinical data to be presented at the CSRS 53rd Annual Meeting. This platform combines AI-driven preoperative planning with 3D-printed, patient-specific implants, building on the success of their lumbar platform.

2025-12

GlobeNewswire

Carlsmed's aprevou00ae Powers First Personalized Cervical Spine Surgery

Carlsmed announced the successful completion of the first aprevou00ae cervical procedure on July 14, 2025, performed by Dr. Joseph Osorio at UC San Diego Health. The aprevou00ae devices are designed with Carlsmed's AI-powered surgical planning platform to match each patient's unique anatomy and alignment needs.

2025-07

SPINEMarketGroup

Carlsmed Announces FDA Clearance for aprevou00ae Cervical Breakthrough Fusion Device

Carlsmed announced FDA 510(k) clearance for the aprevou00ae Cervical ACDF Interbody System, a significant step in advancing patient-specific spine surgery solutions. This clearance follows the FDA's Breakthrough Device designation for aprevou00ae technology for cervical spine disease.

2024-12

GlobeNewswire

Carlsmed's aprevou00ae Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures

Carlsmed's aprevou00ae personalized interbody implants for cervical fusion procedures are now eligible for additional reimbursement through the CMS New Technology Add-On Payment (NTAP) program, starting October 1, 2025. This program supports new medical technologies that demonstrate significant clinical improvement for Medicare beneficiaries.

2025-08

Business Wire

Carlsmed Raises $52.5M in Series C Financing to Advance Personalized Spine Surgery

Carlsmed announced a $52.5 million Series C funding round, co-led by B Capital and U.S. Venture Partners, to accelerate commercialization of its aprevou00ae personalized spine surgery platform for lumbar fusion and develop aprevou00ae for cervical fusions. The cervical fusion platform is expected to launch in 2025.

2024-03

GlobeNewswire

Carlsmed aprevou00ae Lumbar 2-year Data Published in Global Spine Journal

A new retrospective cohort study published in Global Spine Journal demonstrated that Carlsmed's 3D preoperative planning combined with patient-specific aprevou00ae interbody implants significantly reduces mechanical complication-related reoperations in complex adult spinal deformity surgery. The study showed a 74% relative reduction in revision rates compared to conventional stock implants.

2026-01

Medical Device and Diagnostic Industry

Carlsmed Achieves Milestone in AI-Driven Spine Surgery Innovation

Carlsmed recently reported the completion of the first posterior lumbar spine surgery using the aprevou00ae Lumbar Bi-lateral Posterior System, integrating seamlessly with their AI-enabled aprevou00ae platform. This expansion aims to provide a broader range of personalized procedures, leading to better alignment and fewer complications.

2026-02

GlobeNewswire

Carlsmed Announces first corrau2122 personalized Cervical Plating Procedure

Carlsmed announced the first personalized cervical plating procedure using the corrau2122 Cervical Plating System, performed by Dr. Aaron Clark at UCSF. This milestone is part of the company's preparations for the planned commercial launch of the corrau2122 system later in 2026.

2026-02

Frequently Asked Questions

What are Carlsmed's primary AI-powered products for spine surgery?

Carlsmed's flagship product is the aprevou00ae personalized surgery platform, which utilizes AI-enabled software to create optimal surgical plans and patient-specific 3D-printed spine fusion devices for both lumbar and cervical procedures. They also offer the myaprevou00ae app for 3D visualization during surgery and recently launched the corrau2122 Cervical Plating System for personalized cervical fixation.

How does Carlsmed ensure the safety and regulatory compliance of its AI-driven surgical plans and personalized implants?

Carlsmed's implantable devices and software platforms are FDA-cleared for lumbar spine fusion, including anterior, lateral, and transforaminal approaches. Their aprevou00ae cervical technology also received FDA 510(k) clearance and Breakthrough Device designation, recognizing its potential to address unmet clinical needs and deliver superior patient care.

What is the typical pricing structure for Carlsmed's personalized spine surgery solutions, and how is reimbursement handled?

Carlsmed's personalized spinal implants have secured favorable Medicare reimbursement. Their aprevou00ae devices have received New Technology Add-On Payments (NTAPs) and robust reimbursement through new MS-DRGs, which reimburse at higher levels than traditional spine surgery. For cervical fusion procedures, NTAP provides up to an additional $21,125 in reimbursement starting October 1, 2025.

What kind of support and training does Carlsmed offer to surgeons and healthcare administrators adopting their technology?

Carlsmed provides resources including instructions for use (IFUs) and brochures for their aprevou00ae platform. They also offer coding and reimbursement support, though they advise physicians and hospitals to follow local payer policies and verify correct coding procedures.

Does Carlsmed have partnerships with other healthcare organizations or research institutions to further validate its technology?

Yes, Carlsmed has partnered with the International Spine Study Group Foundation (ISSGF) to collect long-term outcomes data on surgical treatment with personalized interbody devices. This collaboration aims to assess the role of aprevou00ae devices in improving patient outcomes and reducing postoperative complications.

What is the financial stability and long-term outlook for Carlsmed as a company?

Carlsmed is a public company that has raised a total funding of $110M over six rounds, including a $52.5M Series C round in March 2024. The company went public on Nasdaq under the ticker 'CARL' in July 2025, with plans to raise over $100 million, indicating a strong financial position and growth trajectory.

How does Carlsmed's AI platform integrate with existing surgical workflows and imaging systems?

Carlsmed's aprevou00ae technology platform is an integrated, end-to-end solution that uses patient CT scans to create precise 3D models of the spine for AI-enabled surgical planning. The myaprevou00ae app provides 3D visualization and detailed plans for intraoperative execution, and the platform supports full surgical workflow from preoperative planning to postoperative digital insights.